ABO and genetic risk factors associated with venous thrombosis ab 59.99 € als Taschenbuch: ABO factor V-Leiden and FVIII are a risk factors associated with venous thrombosis. Aus dem Bereich: Bücher, Wissenschaft, Biologie,
Myopia or nearsightedness was a global public health issue. It is a refractive error, which means that the eye does not refract the light correctly causing the visual images come to a focus in front of the retina of the eyes. It causes myopic individuals have difficulties to see remote object, but can see the near subject obviously. Many factors are associated with higher incidence of myopia. Some of these factors are controllable such diet, habits, and physical activities while some others are uncontrollable such as age, genetic, family history and vision status. An association between ABO blood groups and myopia has been described. The purpose of this study is to find out the association between myopia and ABO blood groups.
In Sudan, Vein Thromboembolism (DVT/PE) increases the rate of morbidity and mortality among young individuals. While the impact of the acquired risk factors in VTE are well established, information's about influencing of hereditary risk factors ( genetic mutations) in VTE and translation of this risk information's to clinical practices are still need to be clarify. This book therefore, aimed to identify the most common hereditary & acquired risk factors associated with VTE and to correlate the finding with the clinical applications of thrombophilia screening tests. Our finding in this book showed that, hereditary risk factors particularly, factor V-Leiden, factor II G20210A mutations, non-O blood group, elevated concentrations of factors VIII and von Willebrand proteins were the most important risk factors for VTE among Sudanese patients. The results showed that, these findings should change the therapeutic policy into lifelong prophylactic therapy in patients with genetics risk factors and individual with high level of Factor VIII. Initial workup for thrombophilia should include these factor but not Prothrombin II G20210A gene mutation.
Merozoite surface protein MSP2 is avaccine candidate antigen of Plasmodium falciparum that is polymorphic in natural populations. In this study we aimed to investigate whether malaria infection in associated with anti-malaria specific IgG, using recombinant proteins derived from the two major allelic types of MSP2 and ABO blood group. The conclusion is the Higher anti-malarial IgG1, IgG3, IgG2 and lower levels of IgG4 were associated with reduced risk of malaria infection. IgG2 is activator of the classical complement pathway, Fc RIIa H131 is essential for handling IgG2 immune complexes. These data suggest that an MSP2 based vaccine should be designed to induce high level antibody responses against the different MSP2 types present globally in P. falciparum populations and that MSP2 could be combined with other P. falciparum antigens to form a multi-component malaria vaccine.
This book introduces the clinical application of ABO-incompatible transplantation. In the first part, it starts with the history, blood group antigen, antibody associated with ABO blood type, pathophysiology and pathology and related knowledge. In the second part, it covers clinical experience sharing of ABO-incompatible of heart, liver, lung and kidney transplantation. It provides a systematic methodologies and protocols.
The downward displacement in stomach cancer mortality among Japanese migrants to the United States and their descendants provides an opportunity to see whether the changes in risk can be associated with changes in customs, occupation or other environmental exposures traceable to migration. Case control studies in two prefectures of Japan and in Hawaii and California undertaken with this objective in mind are described. Some preliminary results from interviewing in Miyagi prefecture on the association of selected items of diet with stomach cancer are presented and discussed. References ArRD, 1., BENTALL, H. H., and RoBERTS, J. cer in Hawaii. Milit. Med. 131, 222-223 A. F ., A relationship between cancer of (1966). stomach and the ABO blood groups. Brit. SEGI, M., and KuRrHARA, M., Cancer mor med J. 1953 I, 799-801. tality for selected sites in 24 countries, BrLLINGTON, B. P., Gastric cancer-relation No. 3, (1960/61). Sendai, Japan, Tohoku ships between ABO bloodgroups, site and University School of Medicine 1964. epidemiology. Lancet 1956 II, 859-862. SMITH, R. L., Recorded and expected mor BucKWALTER, J. A., WoHLWEND, C. B., tality among J apanese of the United States CoLTER, D. C., TmRrcK, R. T., and and Hawaii, with special reference to can KNOWLER, L. A., The association of the cer. ]. nat. Cancer lnst. 17, 459-473 ABO blood groups to gastric carcinoma. (1956).